STOCK TITAN

Planned 7,000-share sale by Bruker (NASDAQ: BRKR) insider detailed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The Form 144 notice for Bruker Corporation discloses an intended sale of 7,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/12/2026 on the NASDAQ. The shares have an indicated aggregate market value of $385,000, compared with 151,941,144 shares of common stock outstanding. The 7,000 shares are shown as acquired on 01/12/2026 from the issuer via a stock option exercise paid in cash for the same amount of shares.

The filing also reports that over the prior three months, Mark R. Munch sold 33,843 shares of Bruker common stock on 01/05/2026, generating $1,680,704 in gross proceeds. The form includes the standard representation that the seller does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 for BRKR disclose?

The Form 144 shows an intended sale of 7,000 shares of Bruker common stock, to be executed through Morgan Stanley Smith Barney LLC on or about 01/12/2026 on the NASDAQ market.

How many Bruker (BRKR) shares are planned for sale and at what value?

The notice covers 7,000 shares of common stock with an indicated aggregate market value of $385,000.

How were the 7,000 Bruker shares being sold under Form 144 acquired?

The 7,000 shares were acquired on 01/12/2026 from the issuer via a stock option exercise, with the purchase price paid in cash.

What prior Bruker share sales are reported in the past 3 months?

The filing states that Mark R. Munch sold 33,843 shares of Bruker common stock on 01/05/2026, receiving $1,680,704 in gross proceeds.

How many Bruker shares are outstanding as referenced in this Form 144?

The Form 144 references 151,941,144 shares of Bruker common stock outstanding in connection with the planned sale.

Which broker is handling the planned Bruker share sale under Form 144?

The intended sale of the 7,000 shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

Bruker Corp

NASDAQ:BRKR

View BRKR Stock Overview

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.13B
103.04M
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA